NASDAQ:VLON

Vallon Pharmaceuticals News Headlines

$5.13
-0.21 (-3.93 %)
(As of 06/21/2021 04:52 PM ET)
Add
Compare
Today's Range
$5.13
$5.50
50-Day Range
$3.66
$5.34
52-Week Range
$3.61
$9.90
Volume55,874 shs
Average Volume86,912 shs
Market Capitalization$34.95 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Vallon Pharmaceuticals (NASDAQ VLON) News Headlines Today

SourceHeadline
Leanne M. Kelly Buys 3,657 Shares of Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) StockLeanne M. Kelly Buys 3,657 Shares of Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) Stock
americanbankingnews.com - June 4 at 6:06 PM
Insider Buying: The Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) Independent Non-Executive Director Just Bought US$72k Worth Of SharesInsider Buying: The Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) Independent Non-Executive Director Just Bought US$72k Worth Of Shares
finance.yahoo.com - May 30 at 2:02 PM
Were Keeping An Eye On Vallon Pharmaceuticals (NASDAQ:VLON) Cash Burn RateWe're Keeping An Eye On Vallon Pharmaceuticals' (NASDAQ:VLON) Cash Burn Rate
nasdaq.com - May 19 at 7:25 AM
Vallon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate UpdateVallon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
finance.yahoo.com - May 13 at 10:45 AM
Vallon Pharmaceuticals Appoints Leanne Kelly as Chief Financial OfficerVallon Pharmaceuticals Appoints Leanne Kelly as Chief Financial Officer
finance.yahoo.com - May 11 at 9:58 AM
Vallon Pharmaceuticals to Present at the Q2 Virtual Investor SummitVallon Pharmaceuticals to Present at the Q2 Virtual Investor Summit
finance.yahoo.com - May 7 at 12:39 PM
Vallon Pharma shares rise 6% on ADAIR updateVallon Pharma shares rise 6% on ADAIR update
seekingalpha.com - April 14 at 5:35 PM
Vallon Pharmaceuticals Continues Advancement of Pivotal Study in Lead Development Program, ADAIR, Toward Potential ApprovalVallon Pharmaceuticals Continues Advancement of Pivotal Study in Lead Development Program, ADAIR, Toward Potential Approval
finance.yahoo.com - April 13 at 9:18 AM
Vallon Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Corporate UpdateVallon Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - March 29 at 9:08 AM
Vallon Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences ConferenceVallon Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 3 at 8:41 AM
Vallon Pharmaceuticals Inc.Vallon Pharmaceuticals Inc.
wsj.com - February 26 at 7:25 AM
Vallon Pharmaceuticals Appoints Marella Thorell to Board of DirectorsVallon Pharmaceuticals Appoints Marella Thorell to Board of Directors
finance.yahoo.com - February 23 at 9:19 AM
News for Vallon Pharmaceuticals Inc Registered ShsNews for Vallon Pharmaceuticals Inc Registered Shs
markets.businessinsider.com - February 15 at 9:45 AM
Vallon Pharmaceuticals Inc.: Vallon Pharmaceuticals Announces Closing of Initial Public OfferingVallon Pharmaceuticals Inc.: Vallon Pharmaceuticals Announces Closing of Initial Public Offering
finanznachrichten.de - February 15 at 9:45 AM
Vallon Pharmaceuticals Inc. Common Stock (VLON)Vallon Pharmaceuticals Inc. Common Stock (VLON)
in.finance.yahoo.com - February 12 at 6:38 PM
Vallon Pharmaceuticals out of the gate with regions first life sciences IPO of 2021Vallon Pharmaceuticals out of the gate with region's first life sciences IPO of 2021
bizjournals.com - February 12 at 6:38 PM
Vallon Pharmaceuticals Announces Pricing of Initial Public OfferingVallon Pharmaceuticals Announces Pricing of Initial Public Offering
finance.yahoo.com - February 12 at 6:38 PM
Vallon Pharmaceuticals Announces Closing of Initial Public OfferingVallon Pharmaceuticals Announces Closing of Initial Public Offering
finance.yahoo.com - February 12 at 6:38 PM
This page was last updated on 6/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.